Drug Type Small molecule drug |
Synonyms 8a |
Target |
Action inhibitors |
Mechanism DHFR inhibitors(Dihydrofolate reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC19H16N6S |
InChIKeyHTJLTZJFFCRUAD-UHFFFAOYSA-N |
CAS Registry2887422-04-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Discovery | China | 12 Sep 2023 |





